About Claritas Rx
Claritas Rx is a digital health venture that brings clarity to the challenges of specialty biopharmaceutical products in the marketplace. Claritas Rx leverages a proprietary technology platform to automate and integrate channel, commercial, and clinical data and help biopharmaceutical companies generate business insights.
Missing: Claritas Rx's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Claritas Rx's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Claritas Rx
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Claritas Rx is included in 1 Expert Collection, including Digital Health.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest Claritas Rx News
Nov 12, 2022
BrightInsight Adds Xealth, Woebot Health and Claritas Rx to the BrightInsight Ecosystem Companies Will Collaborate to Drive Digital Innovation, Adoption and Engagement SAN JOSE, Calif. — BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the expansion of its recently launched BrightInsight Ecosystem , a network of the world’s leading healthcare and technology companies collaborating to solve healthcare’s biggest challenges to drive digital innovation, adoption and engagement. “Transforming healthcare requires a broad, collaborative approach. The BrightInsight Ecosystem partners are leaders from across the healthcare industry, collectively focused on advancing digital innovation to improve patient care globally,” said Kal Patel, M.D., CEO and co-founder of BrightInsight. “We are delighted by the enthusiasm shown by so many industry leaders to join us as we collaborate to drive development of new digital therapies and increase patient engagement.” The BrightInsight Ecosystem, which now includes over 20 global leaders on its roster including bioMérieux, Google Cloud, Lyniate and others, welcomes these new partners: Xealth : Xealth is the driving force behind digital health programs at many of the nation’s largest health systems, connecting clinicians and patients with digital resources that extend care teams and deliver outcomes. Woebot Health : Woebot Health is the world’s first mental health ally for people and businesses, with products that put personal growth in people’s hands, wherever they are. Their pipeline of prescription digital therapeutics and behavioral health products combine artificial intelligence, decades of clinically proven techniques and a relational agent called Woebot, which together form the foundation for mental health solutions that engage at scale and fit right into people’s lives. Claritas Rx : The Claritas Rx platform illuminates the patient experience for specialty biopharmaceutical products, providing actionable insights into patient access, duration of therapy, and other commercial metrics. Why Partners Join the BrightInsight Ecosystem “Digital solutions connect clinicians and patients, leading to better patient outcomes,” said Mike McSherry, CEO and co-founder, Xealth. “Integrating digital solutions into clinical workflows is key to accelerating adoption, alongside enabling health systems to monitor the effectiveness of digital health solutions. We are excited to join with BrightInsight to explore ways patients could potentially benefit from a more coordinated approach between the care teams who order digital therapeutics for their patients and the researchers in life science companies creating innovative therapies.” “Mental health issues such as anxiety and depression can stand in the way of patients getting the most out of their treatments. We’re excited to partner with BrightInsight and its leading biopharma clients to address these challenges, and to help people meaningfully engage in their mental health as they look to achieve better overall health,” said Michael Evers, CEO, Woebot Health. “Claritas Rx’s mission is to help manufacturers see the patient experience in a new light. Being part of the BrightInsight Ecosystem, with the most forward-thinking biopharma, medtech and technology companies, allows us to share and exchange ideas in support of our mission,” said Stuart Kamin, Senior Vice President, Corporate Strategy & Business Development, Claritas Rx. BrightInsight joins General Catalyst’s Health Assurance network In addition, BrightInsight is proud to be a part of General Catalyst’s Health Assurance network—comprised of healthcare technology companies, advisors and experts, investors, and strategically-partnered health systems across the country. The General Catalyst Health Assurance network—through strategic partnerships with leading healthcare systems around the country—covers approximately 10% of the U.S. population for delivery of care. The goal of the Health Assurance network is to drive greater collaboration between technology innovators and healthcare systems to accelerate the digital transformation of care and make it more proactive, accessible and affordable. “General Catalyst’s Health Assurance is focused on shifting the paradigm from a ‘sick care’ system to a resilient, proactive system that’s designed to help people stay well, bend the cost curve through innovation, and make quality care more affordable and more accessible to all,” said Daryl Tol, Head of Health Assurance Ecosystem, General Catalyst. “We’re delighted that BrightInsight is part of the General Catalyst Health Assurance network: they have an important role to play in terms of helping systems pilot regulated digital solutions, standardize data integrations and ultimately accelerate digital health scale and adoption.” MCIF News
Claritas Rx Frequently Asked Questions (FAQ)
When was Claritas Rx founded?
Claritas Rx was founded in 2011.
Where is Claritas Rx's headquarters?
Claritas Rx's headquarters is located at 400 Oyster Point Blvd, South San Francisco.
What is Claritas Rx's latest funding round?
Claritas Rx's latest funding round is Series A.
How much did Claritas Rx raise?
Claritas Rx raised a total of $19.08M.
Who are the investors of Claritas Rx?
Investors of Claritas Rx include Questa Capital.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.